At first, it was thought that the anti-tumor effect by proteasome inhibition resulted from the inhibition of NFκB pathway, as this pathway is involved in several most important processes of tumor growth including cell proliferation, metastasis and angiogenesis. This evidence concerns the gene NFKB1 and neoplasm.